BioCentury
ARTICLE | Clinical News

HIV-IT: Began Phase II trial

December 12, 1994 8:00 AM UTC

Viagene Inc. (VIGN), San Diego Product: HIV-IT(V) non-replicating murine retroviral vector delivering the env and rev genes of HIV-1 to be expressed in non-infected cells, in order to generate a kille...